PATENT CLAIM ANALYSIS

Application Number: 16011263
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "009100"]

Abstract:
A fusion molecule is provided that includes one or more inhibitory nucleic acids, a targeting polypeptide, and a nucleic acid binding moiety. The targeting polypeptide and the nucleic acid binding moiety include specific the amino acid sequences. A fusion molecule is also provided that includes one or more inhibitory nucleic acids, a targeting polypeptide, and a nucleic acid binding moiety adapted to bind a double-stranded RNA or to a small hairpin RNA. The targeting polypeptide being CCL27 or CCL11 or a fragment thereof.

Claim (Index 1):
A fusion molecule comprising one or more inhibitory nucleic acids, a targeting polypeptide, and a nucleic acid binding moiety, wherein said targeting polypeptide and said nucleic acid binding moiety comprise the amino acid sequence of SEQ ID NO: 20 or 22.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 2.21951
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14220726', '12988148', '15138604', '15435233', '15036298']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4369441820318212
- 35 USC 102 Novelty (BERT): 0.5551241801585014
- Combined Prediction Score: 0.4487621818444893
- Mean Citation Score: 345.17072399999995
- Max Citation Score: 414.60916
- Similarity Product: 356.9513528834939

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test